Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma
Conditions: Lymphoma; Multiple Myeloma; Non-Hodgkin Lymphoma; Relapsed Hodgkin's Disease, Adult Intervention: Drug: Isatuximab Sponsors: Divaya Bhutani; Genzyme, a Sanofi Company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials
Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma
Conditions: Lymphoma; Multiple Myeloma; Non-Hodgkin Lymphoma; Relapsed Hodgkin's Disease, Adult Interventions: Drug: Isatuximab; Other: Standard Procedures Sponsors: Divaya Bhutani; Genzyme, a Sanofi Company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
Condition: Non-Hodgkin Lymphoma Interventions: Drug: Epcoritamab; Drug: Lenalidomide; Drug: Ibrutinib; Drug: Rituximab; Drug: Cyclophosphamide; Drug: Doxorubicin Hydrochloride [HCl]; Drug: Prednisone; Drug: Polatuzumab Sponsors: AbbVie; Genmab Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2022 Category: Research Source Type: clinical trials
